Results 81 to 90 of about 1,251,059 (351)

Treatment-Related Decisional Conflict, Quality of Life, and Comorbid Illness in Older Adults with Cancer [PDF]

open access: yes, 2017
As the aging population in the nation increases, cancer diagnoses in this age group will also increase. The many chronic medical conditions associated with older adults are confounded by a diagnosis of cancer.
Kates, PhD, MSN, GNP-BC, Jeannette
core   +1 more source

Early metastasis is characterized by Gr1+ cell dysregulation and is inhibited by immunomodulatory nanoparticles

open access: yesMolecular Oncology, EarlyView.
Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.
Jeffrey A. Ma   +9 more
wiley   +1 more source

Medical oncology [PDF]

open access: yesMedical Journal of Australia, 2002
Ward, R. L., Hawkins, N. J.
openaire   +3 more sources

Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic data

open access: yesMolecular Oncology, EarlyView.
This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.
Rong Zhu   +12 more
wiley   +1 more source

Focal Spot, Fall/Winter 1997 [PDF]

open access: yes, 1997
https://digitalcommons.wustl.edu/focal_spot_archives/1077/thumbnail ...

core   +1 more source

Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy. [PDF]

open access: yes, 2017
Current cell-free DNA (cfDNA) next generation sequencing (NGS) precision oncology workflows are typically limited to targeted and/or disease-specific applications.
Alva, Ajjai S   +31 more
core   +1 more source

Supplementum 274: Abstracts of the Swiss Oncology & Hematology Congress (SOHC)

open access: yesSwiss Medical Weekly, 2023
Swiss Society of Medical Oncology   +2 more
doaj   +1 more source

Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8‐year study of 10 754 patients in Turkey

open access: yesMolecular Oncology, EarlyView.
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci   +6 more
wiley   +1 more source

Focal Spot, Fall/Winter 1994 [PDF]

open access: yes, 1994
https://digitalcommons.wustl.edu/focal_spot_archives/1068/thumbnail ...

core   +1 more source

Molecular subgroups of adult medulloblastoma: a long-term single-institution study [PDF]

open access: yes, 2016
Background Recent transcriptomic approaches have demonstrated that there are at least 4 distinct subgroups in medulloblastoma (MB); however, survival studies of molecular subgroups in adult MB have been inconclusive because of small sample sizes. The aim
Ai, Lin   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy